Aileen McLaren
- Pharmacology top 0.5%
- Molecular Biology
- Oncology top 10%
- Biochemistry top 5%
- Genetics
- Co-authors
- C. Roland WolfColin J. HendersonGraeme J. MoffatJ S MilesLesley M. ForresterDidier CarriéDiana M. E. OttoIan Rosewell
- Topics
- Pharmacogenetics and Drug Metabolism (10 papers)RNA modifications and cancer (7 papers)Glutathione Transferases and Polymorphisms (7 papers)
- Cited by
- PharmacologyBiochemistryOncology
- Partner nations
- United KingdomSwitzerlandUnited States
In The Last Decade
Aileen McLaren
26 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 90
- Pharmacology 678
- Molecular Biology 605
- Oncology 396
- Biochemistry 134
- Genetics 123
Countries citing papers authored by Aileen McLaren
This map shows the geographic impact of Aileen McLaren's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aileen McLaren with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aileen McLaren more than expected).
Fields of papers citing papers by Aileen McLaren
This network shows the impact of papers produced by Aileen McLaren. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aileen McLaren. The network helps show where Aileen McLaren may publish in the future.
Co-authorship network of co-authors of Aileen McLaren
This figure shows the co-authorship network connecting the top 25 collaborators of Aileen McLaren. A scholar is included among the top collaborators of Aileen McLaren based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aileen McLaren. Aileen McLaren is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 6 | |
| 3 | 23 | |
| 4 | 18 | |
| 5 | 31 | |
| 6 | 220 | |
| 7 | 13 | |
| 8 | 53 | |
| 9 | 96 | |
| 10 | 22 | |
| 11 | 79 | |
| 12 | 53 | |
| 13 | 4 | |
| 14 | 65 | |
| 15 | 3 | |
| 16 | 12 | |
| 17 | 27 | |
| 18 | 47 | |
| 19 | 51 | |
| 20 | 1 |
About Aileen McLaren
Aileen McLaren is a scholar working on Pharmacology, Biochemistry and Oncology, having authored 26 papers that have together received 1.3k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (10 papers), RNA modifications and cancer (7 papers) and Glutathione Transferases and Polymorphisms (7 papers). The work is most often cited by research in Pharmacology (678 citations), Biochemistry (134 citations) and Oncology (396 citations). Aileen McLaren has collaborated with scholars based in United Kingdom, Switzerland and United States. Frequent co-authors include C. Roland Wolf, Colin J. Henderson, Graeme J. Moffat, J S Miles, Lesley M. Forrester, Didier Carrié, Diana M. E. Otto, Ian Rosewell, Mark A. Magnuson and M. Lang. Their work appears in journals such as Nucleic Acids Research, Journal of Biological Chemistry and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.